Leonard Braden Michael's Form 4 filing

Enliven Therapeutics, Inc. (ELVN) · filed Apr 25, 2022

Accession no.: 0001567619-22-008867
Filed: Apr 25, 2022
Trade date: Apr 21-22, 2022
Filing delay: 4 days
Rule 10b5-1 plan: Not on the form (before 2023)

Original on SEC EDGAR (opens in a new tab)

This filing lists 2 non-derivative transactions. Open-market purchases total $783.8K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
Owner	Relationship to the company
Leonard Braden MichaelCIK 0001373603	10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade date	Security	Transaction	Shares	Price	Value	Shares after	Ownership	Flags
Apr 21, 2022	Common Stock	PPurchaseAcquired	+552,000	$1.40^F2	+$772,800	2,852,000	Indirect
Apr 22, 2022	Common Stock	PPurchaseAcquired	+8,000	$1.38^F3	+$11,040	2,860,000	Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

The shares were purchased in 1 transaction at $1.40 per share.

Referenced by the price of 1 transaction in Table I.

The shares were purchased in multiple transactions at $1.38 per share.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)